US20230157970A1
University of Texas System
Procedures for targeted treatment of kidney fibrosis include administering to a subject in need of treatment of kidney fibrosis a compound including a plurality of nanoparticle including at least one BCL-2/BCL-xl inhibitor; at least one polymer comprising a member selected from the group …